Long-term Anticoagulation
Long-Term Anticoagulation is a therapeutic strategy involving the prolonged administration of anticoagulant agents to prevent recurrent thrombotic events in patients with persistent hypercoagulable states such as Antiphospholipid Syndrome.
1.1K
Publications
81.4K
Citations
6.8K
Authors
1.7K
Institutions
Publications per year
2017–2026
220
Variants
Long-term Anticoagulant Therapy
1.1K
Dabigatran versus Warfarin in Patients with Atrial Fibrillation
Stuart J. Connolly, Michael D. Ezekowitz, Salim Yusuf et al. · New England Journal of Medicine · 2009 · 11.2K citations · Full text
The Management of Thrombosis in the Antiphospholipid-Antibody Syndrome
Munther A. Khamashta, María José Cuadrado, F Mujić et al. · New England Journal of Medicine · 1995 · 1.5K citations · Full text
1–5 of 1.1K
6.8K
21
h-index
19
h-index
18
h-index
18
h-index
17
h-index
1–5 of 6.8K
1.7K

McMaster University
Hamilton, Canada
36 h-index
229 publications
117.8K citations
Harvard University
Cambridge, United States
20 h-index
109 publications
17.6K citations

University of Padua
Padua, Italy
19 h-index
53 publications
10.6K citations

Uppsala University
Uppsala, Sweden
18 h-index
143 publications
35.7K citations
Inserm
Paris, France
18 h-index
65 publications
7.6K citations
Hamilton Health Sciences
Hamilton, Canada
17 h-index
67 publications
79K citations
University of Insubria
Varese, Italy
17 h-index
40 publications
7K citations

Brigham and Women's Hospital
Boston, United States
17 h-index
81 publications
11.1K citations
1–8 of 1.7K
44 publications · 6.6K citations
34
h-index
Repository · 104 publications · 3.8K citations
33
h-index
36 publications · 1.7K citations
26
h-index
JTH · 31 publications · 2.9K citations
24
h-index
25 publications · 1.3K citations
18
h-index
1–5